Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Menstrual Migraine.

Lisa K Mannix1, Anne H Calhoun, Anne H Calhoun

  • 1Headache Associates, 7908 Cincinnati-Dayton Road, Suite J, West Chester, OH 45069, USA. LKMannixMD@aol.com.

Current Treatment Options in Neurology
|October 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of sphenopalatine ganglion stimulation for chronic cluster headache: a double-blind, randomised controlled trial.

The Lancet. Neurology·2019
Same author

Cognitive-Behavioral Therapy for Insomnia to Reduce Chronic Migraine: A Sequential Bayesian Analysis.

Headache·2018
Same author

Migraine Throughout the Female Reproductive Life Cycle.

Mayo Clinic proceedings·2018
Same author

Understanding Menstrual Migraine.

Headache·2018
Same author

The emerging role of gammaCore® in the management of cluster headache: expert panel recommendations.

The American journal of managed care·2017
Same author

Migraine Treatment in Pregnancy and Lactation.

Current pain and headache reports·2017
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Initial treatment for menstrual migraine (MM) involves lifestyle changes and acute therapies. Preventive strategies, including hormonal therapies or NSAIDs, may be needed for persistent symptoms or specific comorbidities.

Area of Science:

  • Neurology
  • Gynecology
  • Pharmacology

Background:

  • Menstrual migraine (MM) is a debilitating condition linked to hormonal fluctuations.
  • Treatment approaches must consider comorbidities and patient-specific factors.

Purpose of the Study:

  • To outline optimal treatment strategies for menstrual migraine.
  • To discuss the role of acute and preventive therapies, including hormonal and non-hormonal options.

Main Methods:

  • Review of current clinical guidelines and trial data for MM management.
  • Analysis of therapeutic options based on efficacy, comorbidities, and predictability of headache occurrence.

Main Results:

  • Initial MM treatment mirrors general migraine management: lifestyle modifications and acute therapies.

Related Experiment Videos

  • Preventive strategies, such as hormonal therapies or NSAIDs, are indicated for incomplete acute treatment response or specific comorbidities.
  • Daily triptan use during the menstrual window shows potential for significant headache reduction but requires careful adherence.

    • Conclusions:

    • A tailored approach combining acute and preventive therapies is crucial for effective MM management.
    • Hormonal therapies and NSAIDs offer valuable options, particularly when comorbidities are present.
    • Predictable MM occurrence allows for targeted preventive strategies, including daily triptan use.